Search Results

Site Search

TPNUQ genotyping assay - Insights

Ann Moyer, M.D., Ph.D., discusses TPNUQ, Mayo Clinic Laboratories' genotyping test for identifying patients at risk for thiopurine toxicity. Used prior to therapy initiation, our assay evaluates for nuances in both TPMT and NUDT15, which...

Communique - Insights

Communiqué takes a deep dive into how Mayo Clinic Laboratories advances patient care, research, and education through laboratory medicine. Our experts are solving the most serious and complex medical challenges for patients worldwide.

New tests launched in March - Insights

In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

wes-wgs-information-test-ordering-guide.pdf

GEN ETICS +Turnaround time begins upon receipt of all samples and required paperwork. ^Whole blood is the preferred specimen type. ŧCPT codes 81416 or 81426 are applied to proband when a family member comparator is submitted. This code...

Alzheimer's Disease Testing - Mayo Clinic Laboratories

We have developed an innovative evaluation for Alzheimer's disease, which uses CSF biomarkers to achieve a high concordance with amyloid PET scan.

COVID-19 weekly news: April 4-10 2022 - Insights

Topic's Include: Testing wastewater for COVID-19: The clearest path to understanding community infection, and the latest advice about COVID-19 boosters.

Dementia - Insights

Mayo Clinic Laboratories’ comprehensive dementia testing menu includes evaluations for Alzheimer's disease, autoimmune dementia, and rapidly progressive dementia.

Pushing the envelope on personalized medicine - Insights

Recognizing the powerful role genes can play in diagnosing illness and guiding treatment, the Division of Laboratory Genetics and Genomics at Mayo Clinic spearheaded a testing expansion, implementing and upgrading more than 60 advanced...

Mayo Clinic Laboratory and Pathology Research Roundup: November 7, 2023 - Insights

This week's research roundup feature: Cytomegalovirus (CMV) is a significant cause of morbidity and mortality among immunocompromised hosts, including transplant recipients. Antiviral prophylaxis or treatment is used to reduce the incidence...

Applying the Staffing-to-Workload Methodology: Identifying Daily Indirect Effort Needs - Insights

Mike Baisch, Principal Systems Engineer at Mayo Clinic, demonstrates how daily indirect effort tasks contribute to staffing plans and needs in the staffing-to-workload methodology.